Navigation Links
Veracord and Parasoft Partner to Improve Compliance and Reduce Cost
Date:5/26/2009

Veracord™, (www.veracord.com), a privately held consulting company, announced today its partnership with Parasoft® Corporation, a leading provider of automated software solutions. Veracord's comprehensive IT expertise extends the Parasoft award-winning product offering beyond product delivery to quality software IT implementation and compliance. Together, Veracord and Parasoft offer clients in the Life Sciences industry a robust product-to-compliance solution that increases productivity, decreases risk, and ensures quality throughout the software development and implementation cycle.

San Jose, CA (PRWEB) May 26, 2009 -- Veracord™, (www.veracord.com), a privately held consulting company, announced today its partnership with Parasoft® Corporation, a leading provider of automated software solutions. Veracord's comprehensive IT expertise extends the Parasoft award-winning product offering beyond product delivery to quality software IT implementation and compliance. Together, Veracord and Parasoft provide clients in the Life Sciences industry with a robust product-to-compliance solution that increases productivity, decreases risk, and ensures quality throughout the software development and implementation cycle.

Veracord, partnered with Parasoft, offers clients best-in-class software development tools ideally suited for medical device and pharmaceutical companies where risk mitigation and adherence to regulatory compliance remains top priority. Parasoft products focus on end-to-end quality processes from requirement initiation to audit, while improving efficiencies to reduce cost. "Parasoft solutions compliment what Veracord's validation and compliance expertise delivers to its clients--streamlined validation and continuous quality assurance in highly regulated environments," states David Park Schutz, Veracord CEO. "This partnership also strengthens the Veracord and Parasoft commitment to supply improved regulatory compliance while putting into action the risk-based approach to universally address an organization's entire processes in order to leverage its investment across the board." Veracord continues to seek carefully chosen partners that supply unparalleled, cost-effective solutions, ensuring compliance, improved efficiencies, and better utilization of resources to increase employee productivity.

Parasoft shares in its ability to offer more to companies. Where Parasoft delivers automated proven methods for enabling software quality, it now adds Veracord's consulting capabilities in the validation and compliance arena. "Software is not only becoming more of a strategic business differentiator in the life sciences industry, but also it is becoming the primary intermediary between the patient (or user) and the company," states Wayne Ariola, VP of Strategy for Parasoft. "Both good will and ill will about the quality of the medical device or user experience is primarily derived via the interaction with software. This makes the optimization of the software development lifecycle a critical path for innovation and patient/customer satisfaction."

Beginning June, Veracord and Parasoft will announce co-marketing efforts to reach client companies wordwide. Also planned in coming months, targeted communications will more clearly define benefits leveraged in the new alliance.

Parasoft and Veracord will present a strategy and demonstrate a LIVE system that leverages automation to achieve FDA compliance for software validation--at costs that are far reduced from those of manual processes.

Webinar hosted by: Parasoft
Date: Thursday, June 4, 2009
Time: 10:00 a.m. to 11:00 p.m. PT / 1:00 p.m. to 2:00 p.m. ET
Click here and register for this Webinar

About Veracord
Headquartered in San Jose, CA, Veracord (www.veracord.com) serves the FDA regulated life science industry, which includes pharmaceutical, biotechnology, and medical device companies. Veracord offers consulting services nationwide, specializing in validation, compliance, clinical, medical, and regulatory affairs. For more information visit: www.veracord.com

About Parasoft
For 20 years, Parasoft has investigated how and why software errors are introduced into applications. Our solutions leverage this research to deliver quality as a continuous process throughout the SDLC. This promotes strong code foundations, solid functional components, and robust business processes. Whether you are delivering Service-Oriented Architectures (SOA), evolving legacy systems, or improving quality processes--draw on our expertise and award-winning products to increase productivity and the quality of your business applications. For more information visit: www.parasoft.com

Contact:
Elizabeth Park, director of public relations
Veracord
408-294-5500 Ext. 13
epark (at) veracord (dot) com
www.veracord.com

Read the full story at http://www.prweb.com/releases/2009/05/prweb2457184.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Oridion Expands its Presence in the Pre-hospital Market with an OEM Partnership with a leading Defibrillator Manufacturer
2. Feeding America Partner Support Expedites Disaster Relief and Recovery Efforts
3. Health and Wellness Partners, Inc., A Wholly Owned Subsidiary of Zealous Inc., Launches Organix+
4. Partnership for Prescription Assistance Prepared to Help Montana Workers Hurt by Recession
5. University of Pennsylvania, Montgomery County Partner on Integrated, Interoperable System Design for Child Welfare
6. Mosaica Partners Briefing Paper Identifies Leading Practices for States and Regions to Leverage ARRA Stimulus Funds for HIE
7. MIT is pleased to announce that it has signed the Joint Venture agreement with its Chinese partners and has received an initial order of 120 units for Animal vaccination
8. Safeway Earns Easter Seals All-Time Top Corporate Partner Designation
9. Hummingbird Coaching Partners with Leeza's Place to Help Caregivers “Take Your Oxygen First”
10. Safeway Earns Easter Seals' All-Time Top Corporate Partner Designation
11. The Oro Organization, LLC Partners with Medical Hair Restoration to Launch New Website USHairReplacement.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: